Agenus Inc (AGEN)
13.24
+1.13
(+9.33%)
USD |
NASDAQ |
May 01, 14:21
Agenus Cash and Short Term Investments (Quarterly): 76.11M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 76.11M |
| September 30, 2023 | 106.30M |
| June 30, 2023 | 157.85M |
| March 31, 2023 | 189.23M |
| December 31, 2022 | 193.36M |
| September 30, 2022 | 218.23M |
| June 30, 2022 | 238.33M |
| March 31, 2022 | 262.69M |
| December 31, 2021 | 306.92M |
| September 30, 2021 | 261.53M |
| June 30, 2021 | 73.54M |
| March 31, 2021 | 119.37M |
| December 31, 2020 | 99.87M |
| September 30, 2020 | 114.14M |
| June 30, 2020 | 79.17M |
| March 31, 2020 | 92.28M |
| December 31, 2019 | 61.81M |
| September 30, 2019 | 93.27M |
| June 30, 2019 | 121.72M |
| March 31, 2019 | 158.31M |
| December 31, 2018 | 53.05M |
| September 30, 2018 | 46.17M |
| June 30, 2018 | 43.16M |
| March 31, 2018 | 52.35M |
| December 31, 2017 | 60.19M |
| Date | Value |
|---|---|
| September 30, 2017 | 70.05M |
| June 30, 2017 | 96.77M |
| March 31, 2017 | 123.82M |
| December 31, 2016 | 76.44M |
| September 30, 2016 | 95.40M |
| June 30, 2016 | 123.29M |
| March 31, 2016 | 148.23M |
| December 31, 2015 | 171.67M |
| September 30, 2015 | 199.13M |
| June 30, 2015 | 139.64M |
| March 31, 2015 | 79.30M |
| December 31, 2014 | 40.22M |
| September 30, 2014 | 52.91M |
| June 30, 2014 | 62.82M |
| March 31, 2014 | 73.49M |
| December 31, 2013 | 27.35M |
| September 30, 2013 | 30.20M |
| June 30, 2013 | 13.44M |
| March 31, 2013 | 17.21M |
| December 31, 2012 | 21.47M |
| September 30, 2012 | 24.76M |
| June 30, 2012 | 25.46M |
| March 31, 2012 | 24.59M |
| December 31, 2011 | 10.75M |
| September 30, 2011 | 14.73M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
61.81M
Minimum
Dec 2019
306.92M
Maximum
Dec 2021
150.83M
Average
119.37M
Median
Mar 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Protalix BioTherapeutics Inc | 44.56M |
| InfuSystems Holdings Inc | 0.231M |
| PAVmed Inc | 19.64M |
| Allogene Therapeutics Inc | 448.70M |
| Pfizer Inc | 12.69B |